To be able to contribute to the development of new drugs is very exciting! I am passionate about helping people to a better life – says Johan Kördel
Sound Bioventures strategy is to invest in private clinical stage therapeutics companies. In the interview Johan expands on the opportunity to create private spin-outs from public companies, that in some cases trade for less than their cash, and raise money from venture funds to allow clinical programs to advance. This opportunity has arisen with the suppressed public valuations the biotech sector has seen the last year. Read the full interview below.
BioStock is Scandinavia’s leading digital news and analysis service with an exclusive focus on companies in the Life Science sector. BioStock’s content is aimed at investors and representatives of companies and organizations in biotechnology, medical technology, diagnostics and drug development. BioStock’s daily news updates are followed by a majority of decision-makers at management level in Nordic life science.